Composite Biomarker Image for Advanced Visualization in Histopathology.

Area of Science:

• Digital pathology
• Biomarker analysis
• Cancer diagnostics

Background:

• Immunohistochemistry (IHC) biomarkers are crucial for cancer diagnosis and subtyping.
• Comparing IHC and hematoxylin and eosin (H&E) Whole Slide Images (WSIs) is essential but challenging.
• Current methods are subjective, time-consuming, and prone to errors.

Purpose of the Study:

• To develop a novel digital pathology approach for improved visualization and analysis of IHC biomarkers.
• To introduce the Composite Biomarker Image (CBI) concept for efficient clinical workflows.
• To reduce subjectivity and errors in cancer diagnosis by integrating multi-biomarker data.

Main Methods:

• Image alignment of IHC and H&E WSIs within a unified coordinate system.
• Filtering of positive/negative IHC regions based on pathologist recommendations.
• Integration of filtered biomarker images into a single Composite Biomarker Image (CBI) using a fuzzy inference system.

Main Results:

• The proposed system generates CBI images that enhance visualization of IHC biomarker expression.
• Qualitative evaluation by expert pathologists confirmed the utility of CBI in identifying suspected target tissues.
• The CBI approach facilitates easier identification of relevant regions for further assessment.

Conclusions:

• Composite Biomarker Images (CBI) offer a more efficient and potentially less subjective method for cancer diagnosis.
• This digital pathology tool aids pathologists in pinpointing areas of interest across multiple biomarker stains.
• The CBI concept has the potential to improve the accuracy and speed of cancer subtyping and diagnosis.